Literature DB >> 2371713

T-cell receptor beta-chain DNA polymorphism frequencies in healthy HLA-DR homozygotes.

P Charmley1, P Concannon, R A Gatti.   

Abstract

In view of numerous recent reports of T-cell receptor (TCR) beta-chain/disease associations with HLA-associated diseases, we tested the possibilities that associations might exist directly between these two gene complexes at the level of the germline DNA. We determined frequencies of five TCR-beta DNA polymorphisms in 33 HLA-DR2/2 homozygotes, 29 HLA-DR3/3 homozygotes and 42 HLA-DR4/4 homozygotes. The control population (n = 74) was chosen without "bias toward" their HLA-DR genes. We selected DR2, DR3 and DR4 homozygotes because they have been the most frequently involved in HLA-DR associated diseases. Our results indicate that the recent reports in the literature of TCR-beta/disease associations can not be explained by a significantly different distribution of TCR-beta genes in HLA-DR2+, -DR3+, or -DR4+ subpopulations. Our results also suggest that if co-evolution between TCR-beta and MHC haplotypes does exist, the selective pressures in recent generations have not been strong enough to significantly alter the germline TCR-beta gene frequencies in HLA-DR2+, -DR3+, or -DR4+ subpopulations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2371713     DOI: 10.1111/j.1399-0039.1990.tb01773.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

Review 1.  On genetic components in autoimmunity: a critical review based on evolutionarily oriented rationality.

Authors:  J T Epplen
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

2.  T cell receptor haplotypes in families of patients with insulin-dependent diabetes mellitus.

Authors:  H Kelly; M J Garlepp
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

3.  Novel members and germline polymorphisms in the human T-cell receptor Vb6 family.

Authors:  M Gomolka; C Epplen; J Buitkamp; J T Epplen
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.